Clinical Trial Details
| Trial ID: | L2555 |
| Source ID: | NCT00058981 |
| Associated Drug: | Diapep277 |
| Title: | Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA) |
| Acronym: | |
| Status: | TERMINATED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes, Autoimmune |
| Interventions: | DRUG: DiaPep277 |
| Outcome Measures: | |
| Sponsor/Collaborators: | Sponsor: DeveloGen Israel, Ltd. |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 100 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT |
| Start Date: | 2002-10 |
| Completion Date: | 2007-05 |
| Results First Posted: | |
| Last Update Posted: | 2009-03-19 |
| Locations: | University of Alabama at Birmingham Endocrinology Department, Birmingham, Alabama, 35294, United States|University of Colorado Hospital Endocrinology Practice, Aurora, Colorado, 80010, United States|University of Kentucky Department of Internal Medicine, Lexington, Kentucky, 40536, United States|Washington University School of Medicine Endocrinology/Metabolic Dept, Saint Louis, Missouri, 63110, United States|North Shore Diabetes and Endocrine Associates, New Hyde Park, New York, 11042, United States|Diabetes & Glandular Disease Research Associates, San Antonio, Texas, 78229-4801, United States|DVA Puget Sound Health Care System Endocrinology (III) Department, Seattle, Washington, 98108, United States |
| URL: | https://clinicaltrials.gov/show/NCT00058981 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|